NM_178335.3:c.1242+10G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_178335.3(CCDC50):​c.1242+10G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.49 in 1,601,236 control chromosomes in the GnomAD database, including 198,106 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.58 ( 27048 hom., cov: 32)
Exomes 𝑓: 0.48 ( 171058 hom. )

Consequence

CCDC50
NM_178335.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.478

Publications

11 publications found
Variant links:
Genes affected
CCDC50 (HGNC:18111): (coiled-coil domain containing 50) This gene encodes a soluble, cytoplasmic, tyrosine-phosphorylated protein with multiple ubiquitin-interacting domains. Mutations in this gene cause nonsyndromic, postlingual, progressive sensorineural DFNA44 hearing loss. In mouse, the protein is expressed in the inner ear during development and postnatal maturation and associates with microtubule-based structures. This protein may also function as a negative regulator of NF-kB signaling and as an effector of epidermal growth factor (EGF)-mediated cell signaling. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]
CCDC50 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 44
    Inheritance: AD, Unknown Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 3-191380942-G-A is Benign according to our data. Variant chr3-191380942-G-A is described in ClinVar as Benign. ClinVar VariationId is 48150.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.799 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCDC50NM_178335.3 linkc.1242+10G>A intron_variant Intron 9 of 11 ENST00000392455.9 NP_848018.1 Q8IVM0-2
CCDC50NM_174908.4 linkc.714+10G>A intron_variant Intron 8 of 10 NP_777568.1 Q8IVM0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCDC50ENST00000392455.9 linkc.1242+10G>A intron_variant Intron 9 of 11 1 NM_178335.3 ENSP00000376249.4 Q8IVM0-2
CCDC50ENST00000392456.4 linkc.714+10G>A intron_variant Intron 8 of 10 1 ENSP00000376250.4 Q8IVM0-1

Frequencies

GnomAD3 genomes
AF:
0.578
AC:
87672
AN:
151792
Hom.:
26994
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.806
Gnomad AMI
AF:
0.344
Gnomad AMR
AF:
0.566
Gnomad ASJ
AF:
0.505
Gnomad EAS
AF:
0.666
Gnomad SAS
AF:
0.522
Gnomad FIN
AF:
0.444
Gnomad MID
AF:
0.560
Gnomad NFE
AF:
0.467
Gnomad OTH
AF:
0.546
GnomAD2 exomes
AF:
0.534
AC:
127772
AN:
239112
AF XY:
0.522
show subpopulations
Gnomad AFR exome
AF:
0.809
Gnomad AMR exome
AF:
0.627
Gnomad ASJ exome
AF:
0.506
Gnomad EAS exome
AF:
0.684
Gnomad FIN exome
AF:
0.447
Gnomad NFE exome
AF:
0.468
Gnomad OTH exome
AF:
0.508
GnomAD4 exome
AF:
0.481
AC:
696616
AN:
1449326
Hom.:
171058
Cov.:
30
AF XY:
0.480
AC XY:
345885
AN XY:
720928
show subpopulations
African (AFR)
AF:
0.813
AC:
26900
AN:
33074
American (AMR)
AF:
0.619
AC:
27258
AN:
44028
Ashkenazi Jewish (ASJ)
AF:
0.504
AC:
13093
AN:
25972
East Asian (EAS)
AF:
0.645
AC:
25316
AN:
39248
South Asian (SAS)
AF:
0.518
AC:
44076
AN:
85130
European-Finnish (FIN)
AF:
0.444
AC:
23575
AN:
53052
Middle Eastern (MID)
AF:
0.468
AC:
2684
AN:
5740
European-Non Finnish (NFE)
AF:
0.457
AC:
503814
AN:
1103230
Other (OTH)
AF:
0.500
AC:
29900
AN:
59852
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
17130
34260
51391
68521
85651
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15310
30620
45930
61240
76550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.578
AC:
87781
AN:
151910
Hom.:
27048
Cov.:
32
AF XY:
0.578
AC XY:
42880
AN XY:
74212
show subpopulations
African (AFR)
AF:
0.806
AC:
33441
AN:
41476
American (AMR)
AF:
0.566
AC:
8635
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.505
AC:
1749
AN:
3464
East Asian (EAS)
AF:
0.665
AC:
3429
AN:
5154
South Asian (SAS)
AF:
0.522
AC:
2515
AN:
4820
European-Finnish (FIN)
AF:
0.444
AC:
4671
AN:
10530
Middle Eastern (MID)
AF:
0.571
AC:
168
AN:
294
European-Non Finnish (NFE)
AF:
0.467
AC:
31709
AN:
67898
Other (OTH)
AF:
0.544
AC:
1150
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1745
3490
5235
6980
8725
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
728
1456
2184
2912
3640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.544
Hom.:
7088
Bravo
AF:
0.599
Asia WGS
AF:
0.626
AC:
2171
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

1242+10G>A in Intron 09 of CCDC50: This variant is not expected to have clinical significance because it is not located within the conserved splice consensus se quence and has been identified in 46.1% (3234/7016) of European American chromos omes from a broad population by the NHLBI Exome Sequencing Project (http://evs.g s.washington.edu/EVS; dbSNP rs211043). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 09, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Autosomal dominant nonsyndromic hearing loss 44 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
9.8
DANN
Benign
0.68
PhyloP100
0.48
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs211043; hg19: chr3-191098731; COSMIC: COSV66667470; API